SLRN Bathi mangsa ngarep Acelyrin Inc.

Simbol resmi perusahaan Acelyrin Inc. (SLRN)

The financial stability of Acelyrin, Inc. (SLRN) remains dependent on the results of medical trials, as the company lacks a consistent revenue stream. The company's target profit reflects the dynamics of expected earnings, where the mark reflects the latest data. Revenues are based on the implementation of isokibep immunotherapy for skin and joints. Speculative potential is supported by patents in the field of treating severe eye diseases.

acelyrin.com (SLRN): Bathi resik sing dikarepake saka 04.07.2022 nganti 15.11.2026

ACELYRIN, Inc. - rincian analitis lan metrik utama (SLRN)

- rega saham lan konsensus proyeksi valuasi:
Analisis fundamental perusahaan:SLRN, ACELYRIN
Produk dadi Acelyrin Inc.

For Acelyrin, Inc. (SLRN), which is currently pivoting its R&D strategy, the estimated future profit chart serves as an indicator of market confidence in the new management. This metric quantifies the expected business return by translating long-term prospects into specific cash equivalents. These values are derived from analyst consensus forecasts regarding future cash flows. Steady growth of the curve confirms the validity of the investments, while declining expectations signal fundamental risks.

Analisis pesaing Acelyrin, Inc.

Bathi mangsa ngarep HLN|Proyeksi bathi mangsa ngarep Kenvue Corp|Bathi mangsa ngarep VRNA (Verona Pharma Corp)|MENS (Jyong Bio) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Ligand Pharmaceuticals Incorporated LGND|Amneal (AMRX) - Bathi resik sing dikarepake|PRGO: Bathi mangsa ngarep|Alvotech SA - Bathi resik mangsa ngarep|LQDA: Proyeksi bathi mangsa ngarep|Galapagos Genomics - Penghasilan resik sing dikarepake|ANIP (ANI Pharmaceuticals Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake mannkindcorp.com MNKD|Bathi sing dikarepake Amphastar Pharmaceuticals, Inc. (AMPH)|PCRX (Pacira Pharmaceuticals) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep SPRY (ARS Pharmaceuticals Inc)|Bathi resik mangsa ngarep TBPH (Theravance)|AQST - Bathi sing dikarepake|scPharmaceuticals (SCPH) - Bathi mangsa ngarep|TECX: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik TNXP|Bathi sing dikarepake China SXT Pharmaceuticals, Inc.|EPRX: Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep BHST|EXOZ - Bathi resik sing dikarepake|Proyeksi bathi mangsa ngarep ORMP (oramed.com)|Proyeksi bathi mangsa ngarep enterabio.com ENTX|HYFT - Bathi sing dikarepake|Prakiraan bathi perusahaan ABVC BioPharma, Inc ABVC|CPIX: Proyeksi bathi mangsa ngarep|Quantum BioPharma Ltd - Penghasilan resik sing dikarepake|Bathi mangsa ngarep FGEN|Telomir Pharmaceuticals, Inc. - Bathi forward|Proyeksi bathi mangsa ngarep RANI|SNYR (Synergy CHC) - Penghasilan resik sing dikarepake|Bathi sing dikarepake Rallybio RLYB|Lexaria Bioscience (LEXX) - Bathi resik sing dikarepake|PULM - Bathi sing dikarepake|Prakiraan bathi perusahaan Pheton Holdings PTHL|APM (Aptorum) - Bathi mangsa ngarep|Lyra Therapeutics, Inc. (LYRA) - Proyeksi bathi mangsa ngarep|IBO (impactbiomedinc.com) - Proyeksi bathi mangsa ngarep|TNFA (TNF Pharmaceuticals) - Bathi resik mangsa ngarep|Bathi sing dikarepake cbdmd.com (YCBD)|Prakiraan bathi perusahaan PainReform Ltd|Proyeksi bathi mangsa ngarep CYTO (Altamira Therapeutics Ltd.)|Lipella Pharmaceuticals (LIPO) - Bathi resik sing dikarepake|OPTN - Bathi sing dikarepake|Pieris Pharmaceuticals - Bathi resik mangsa ngarep|PROC (Procaps Group) - Bathi mangsa ngarep|PTPI - Prakiraan bathi perusahaan|Bathi sing dikarepake Qilian International Holding Group Limited|TFF Pharmaceuticals (TFFP) - Prakiraan bathi perusahaan